Other

Swiss pharma Novartis ups full-year sales outlook (Update)

Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...

Other

German drug maker Merck ups forecast for 2013

German chemicals and pharmaceuticals giant Merck KGaA said Thursday it is raising its full-year operating profit forecast thanks to improving sales and positive cost-cutting effects.

Health

Nonprofit hospitals earn substantial profits

Seven of the 10 most profitable hospitals in the United States in 2013 - each earning more than $163 million in profits from patient care services—were nonprofit hospitals, according to new research from the Johns Hopkins ...

Health

Managers' religious affiliation impacts hospital strategy

Protestant non-profit hospitals in Germany offer fewer treatment types, but focus more on complex treatments. By contrast, Catholic German hospitals offer more treatment types but focus on less complex treatments. This is ...

Vaccination

AstraZeneca says Covid vaccine sales top $1.0 bn

British pharmaceuticals giant AstraZeneca said Thursday that its COVID jab generated $1.2 billion (1.0 billion euros) in sales in the first half of the year as global vaccination programmes accelerated.

Other

Amgen 3Q profit jumps 24 pct. on stronger sales

Biotech drugmaker Amgen Inc. said Tuesday that its third-quarter profit jumped 24 percent, trouncing analysts' expectations, as sales of more than a half-dozen of its drugs increased by double digits.

page 8 from 11